Cargando…
Disease Modifying Agents for Multiple Sclerosis
OBJECTIVE: To summarize major clinical trials which evaluate the efficacy and safety data of approved disease modifying agents for the treatment of various types of multiple sclerosis. DATA SOURCES: A MEDLINE (1966 to August 2008) search of clinical trials using the terms multiple sclerosis, interfe...
Autores principales: | Hilas, Olga, Patel, Priti N, Lam, Sum |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024587/ https://www.ncbi.nlm.nih.gov/pubmed/21258574 http://dx.doi.org/10.2174/1874205X01004010015 |
Ejemplares similares
-
Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007) -
Disease-modifying agents in multiple sclerosis
por: Coyle, P. K.
Publicado: (2009) -
Multiple Sclerosis: Overview of Disease-Modifying Agents
por: Finkelsztejn, Alessandro
Publicado: (2014) -
Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness
por: Järvinen, Elina, et al.
Publicado: (2016) -
Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis
por: Earla, Jagadeswara R, et al.
Publicado: (2020)